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Abstract: The Short Form of the Fonseca Anamnestic Index (SFAI) is a simple and quick questionnaire
used for screening temporomandibular disorders (TMDs). The present study aimed to validate the
Spanish version of the SFAI in patients with TMDs. The study sample comprised 112 subjects
(50 TMDs and 52 controls). Test–retest reliability, factorial validity, internal consistency, concurrent
validity, and the SFAI’s ability to discriminate between TMDs subjects and healthy controls were
analyzed using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD protocol) as the
reference. Factor analysis showed a single factor that explained 63% of the total variance. Cronbach’s
alpha was 0.849. The reliability of the items measured with the Kappa index showed values from
0.767 to 0.888. Test–retest reliability was substantial (intraclass correlation coefficient = 0.837). The
total SFAI score showed a significant correlation with orofacial pain, vertigo, and neck disability
measurements. For a cut-off point of >10 points, the SFAI showed a sensitivity of 78% and specificity
of 78.85% at differentiating between TMDs patients and healthy subjects, with an area under the curve
(AUC) of 0.852. The Spanish version of the SFAI is a valid and reliable instrument for diagnosing
people with TMDs and shows generally good psychometric properties.
Keywords: temporomandibular joint syndrome; reproducibility of results; surveys and questionnaires;
validation study
1. Introduction
Temporomandibular disorders (TMDs) are orofacial pain problems characterized by
pain in the facial and mandibular structures [1]. The International Association for the
Study of Pain (IASP) defines orofacial pain as “perceived pain in the face and/or oral
cavity” caused by diseases or disorders of the nervous system, nearby structures, or distant
structures [2]. The main characteristic of TMDs is pain in the temporomandibular joint
(TMJ) area. However, it also affects cranial, cervical, and facial muscles, with limitation
of mandibular movement and the presence of noises such as clicks and crackles during
movement of the mandible [1].
TMD may affect up to 50% of the general population [3,4], producing a high burden
on health care services. A correct diagnosis of TMDs must be established by anamnesis,
physical examination, and, if necessary, diagnostic imaging tests [5]. This process is crucial
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to properly treat the affected person, as a wrong diagnosis leads to incorrect treatment and
therefore has negative repercussions on the patient’s quality of life [6].
Some authors have defended the need to address TMDs in primary care, enabling
better results for patients and maintaining the skill level and experience of specialist services
in secondary care [7]. However, TMDs usually present concomitantly with other very
prevalent disorders such as tinnitus [8], headache [9], or neck pain [10], and consequently
can go unnoticed with resultant delay in health care. Therefore, TMD screening is essential
for correctly establishing personalized attention.
The Short Form of the Fonseca Anamnestic Index (SFAI) [11] is a self-implemented
test that was created and validated in 2018 in Brazil by Fernandes Pires and collaborators
from the Fonseca Anamnestic Index (FAI) [12]. The SFAI has five items and is a quick
and straightforward questionnaire used to evaluate TMD, providing the opportunity to
optimize the diagnostic and screening process. Currently, only the original validation
in Portuguese [11], built from the elimination of five questions from the original FAI, is
available. The SFAI has shown a very good capacity to predict TMDs when compared to
the main benchmark, the Diagnostics Criteria for Temporomandibular Disorder protocol
(DC/TMD) [13]. The FAI was recently translated and cross-culturally adapted to Span-
ish [14], although to date, its short version has not been validated for use in the Spanish
population despite its ease of use and application. As with the original version, the Spanish
version of the SFAI was constructed by extracting five items from the ten-item version.
The objective of this study was to validate the SFAI in the Spanish population and
assess its psychometric properties in patients with TMDs. This study hypothesized that the
Spanish SFAI presents good psychometric properties, with a monofactorial structure, good
internal consistency and acceptable reliability, moderate concurrent validity with respect to
other diagnostic tools, and good diagnostic accuracy with respect to the gold standard, the
DC/TMD protocol.
2. Materials and Methods
2.1. Participants
A cross-sectional questionnaire validation study was conducted to meet the objectives
of this study. Ethics approval from the Research Ethics Committee of Jaen was obtained
(Date: 26 September 2019; code: FonsecaUJA). This study was designed in accordance
with the Declaration of Helsinki and the code of Good Researching Practices of University
of Jaén, based on the applicable laws and regulations. All subjects participating in the
study had to provide written informed consent. The sample selection was performed
in the FisioMedic clinic (Dos Hermanas, Spain) among all those patients who attended
the Physiotherapy, General Medicine, Traumatology, and Stomatology services between
25 May 2020 and 26 August 2020. Doctors of the different services informed potential
participants about the study and derivated the subjects to the researchers for further
information after. A researcher was in charge of recruitment by telephone interview after
a first telephone call. To calculate the sample size, we followed the calculations obtained
in studies with different types of samples that recommend a minimum of 20 subjects for
reliability studies and a minimum of 40 subjects for concurrent validity studies [15]. The
sample of subjects also had to meet the criterion of a minimum number of five and an
optimal number of 10 subjects for each item of the instrument to guarantee factor validity
and internal consistency analyzes [16]. As the tool has five items, a total of 50 patients were
required.
Patients 18 years or older and diagnosed with pain-related TMD by the DC/TMD were
considered eligible for this study. Severe neurological or psychiatric pathologies that could
influence the correct completion of the questionnaires or data provided to researchers (such
as dementia, Alzheimer’s, schizophrenia, Parkinson’s or amyotrophic lateral sclerosis)
were considered as a reason for exclusion from the study. Patients under treatment with
anti-depressants or opioids were also excluded. Furthermore, a sample of healthy subjects
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who did not meet the DC/TMD diagnostic criteria for TMDs was used to test the ability of
the SFAI to discriminate between patients and healthy subjects.
2.2. Measurements
First, interviews were conducted with the participants to collect demographic data
such as sex, age, educational level, work situation, height, weight, body mass index (BMI),
smoking habits, alcohol intake, and physical activity level. The interviewer in charge
of the clinical measurements was a physician with 20 years of experience and who was
appropriately trained in the instruments used.
The DC/TMD examination protocol [17] is composed of the most widely used di-
agnostic criteria for temporomandibular disorders. This instrument presents three major
components: A questionnaire on symptoms (assesses muscle and joint pain, type of bite,
jaw movements, presence of headache in the last 30 days, opening pattern, joint noises,
and blockages); a protocolized clinical examination; and the diagnostic algorithms. Finally,
utilizing a diagnostic tree, the instrument differentiates between diagnostic categories
(pain-related TMD, headache, intra-articular disorder, degenerative joint disorder, and/or
subluxation). Neither the researcher in charge of the general assessment nor the partici-
pants were aware of the DC/TMD examination protocol results, which another researcher
performed to avoid risk of bias.
The Fonseca Anamnestic Index (FAI) was developed and validated in 1992 [12]. This
index is composed of 10 questions with three response options (0 = no; 5 = sometimes;
and 10 = yes), with an overall score that ranges from 0 to 100. The FAI aims to evaluate
the presence or absence of TMD symptoms and their severity, classifying them as mild,
moderate, or severe. SFAI was obtained after factorial analysis, extracting items 1–3, 6,
and 7 from the FAI [12]. The Spanish version of the SFAI was obtained by extracting
the appropriate items from the Spanish version of the FAI (File S1), which was recently
translated and cross-culturally adapted by Sánchez-Torrelo et al. [14].
To evaluate pain intensity, the Numeric Pain Rating Scale (NRS) was chosen. This
is a self-implemented scale on pain intensity perception. The score ranges from 0 (total
absence of pain) to 10 (maximum and extreme pain that the patient is capable of imagining),
presented in an increasing manner from left to right; the subject would have to mark the
answer considered with a cross [18]. In this study, the participants recorded separately on
two independent NRS scales orofacial pain and neck pain.
The 12-Short Form Health Survey was chosen to assess health-related quality of life in
this study. This is a simpler and quicker version of the SF-36, being self-administered and
evaluating general quality of life from both a physical and an emotional point of view. It is
composed of 12 questions that present a variable number of answers. The final score of the
test is obtained by a statistical processing instrument that provides in a more exact way the
value of the physical and mental summary scores with a value ranging from 0 to 100 [19].
The Dizziness Handicap Inventory (DHI) was used to measure dizziness and vertigo
sensations. This questionnaire is a self-implemented scale used to identify lack of balance
and vertigo conditions. It consists of 25 questions that can be answered as “no”, “some-
times”, or “yes”. This inventory identifies physical, functional, and emotional problems
related to dizziness. Each dimension is composed of different questions distributed in
random order throughout the test [20–22].
The Headache Impact Test (HIT-6) is a self-administered questionnaire on headaches.
It contains six questions and five possible answers for each question: “always”, “very
often”, “sometimes”, “rarely”, and “never”. A numerical score results from the sum of
the answers. This questionnaire has been adapted and validated for peninsular Spanish
speakers [23] and several other languages.
The Neck Disability Index (NDI) was used to measure disability produced by neck
pain. This questionnaire consists of ten questions that can be answered on a six-point
scale from least (0) to most disability (5). The final score is the sum of the answers, with a
resulting range from 0 to 50. The final score is categorized as: “no disability” if the result is
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0–4, “moderate disability” for the range 15–24, and “complete disability” for a score in the
range 35–50 [24].
2.3. Statistical Analysis
SPSS 20.0 statistical package (SPSS Inc, Chicago, IL, USA) and MedCalc Statistical Soft-
ware version 19.1.5 (MedCalc Software, Ostend, Belgium) were used for data management
and analysis. Means and standard deviations for continuous variables and frequencies and
percentages for categorical variables were calculated to describe the data. The Kolmogorov–
Smirnov test was selected to verify the normality of the continuous variables, and the
Levene test was used to test the homoscedasticity of the samples. To analyze possible
differences between subjects and controls, the Student’s t test was used for continuous
variables and the chi-square test for categorical variables. The confidence level was set at
95% (p < 0.05).
Factorial validity was evaluated by using principal component analysis (PCA) with
Kaiser varimax rotation. Bartlett’s test and the Kaiser–Meyer–Olkin (KMO) measure of
sampling adequacy was obtained [25].
Test–retest reliability was determined using the intraclass correlation coefficient (ICC
2,1 by Shrout and Fleiss) [26]. Reliability was considered poor (ICC < 0.40), moderate
(ICC = 0.40–0.75), substantial (ICC = 0.75–0.90), or excellent (ICC > 0.90) [26]. To analyze
the precision of the score, the standard error of measurement (SEM) was calculated as
standard deviation (SD) at baseline (σbase) minus the square root of (1-Rxx), where Rxx
is the reliability index (ICC) [27]. The reliability between the two measurements of each
item was analyzed using the weighted Kappa coefficient [28]. The reliability was by
agreement considered null (Kappa = 0.00), insignificant (Kappa 0.00 to 0.20), discreet
(Kappa = 0.21–0.40), moderate (Kappa = 0.41 to 0.60), substantial (Kappa = 0.61 to 0.80),
and almost perfect (Kappa = 0.81–1.00) [29]. Additionally, the MDC was calculated at a
95% confidence level (MDC95) as follows: MDC95 = 1.96 × σbase ×
√
1− ICG, where 1.96
is the z-value corresponding to the 95% confidence interval (MDC95). The MDC provides a
good opportunity for translating the reliability index into units of change of the instrument.
In addition, Bland–Altman plots were obtained to evaluate the limits of agreement [26].
Cronbach’s α coefficient was used to measure internal consistency. The α coefficient
was considered poor if it was less than 0.70, and good if it was between 0.70 and 0.90; it
was interpreted as indicating redundancy if α was greater than 0.90 [30].
Pearson’s correlation coefficient was selected for the concurrent validity analysis of
the SFAI with the NDI, DHI, HIT-6, SF-12, and NRS. Correlation was considered poor for
values below 0.30, moderate if it was between 0.30 and 0.50, and strong if it was higher
than 0.50 [31].
The SFAI total score’s ability to discriminate between TMD and healthy subjects was
analyzed using receiver operating characteristic (ROC) curves. Patients with or without
TMDs were classified according to the DC/TMD protocol criteria, and the SFAI total score
was used as the variable. The area under the curve (AUC) was obtained as a measure of
the parameter’s ability to discriminate between subjects with TMDs and healthy controls.
The AUC was considered statistically significant when the 0.5 value was not included
between the 95% confidence interval [32]. The accuracy was considered low when AUC
was between 0.5 and 0.7, good when between 0.7 and 0.9, and high when greater than
0.9 [33].
3. Results
The sample consisted of 102 subjects, 50 belonging to the group of patients with
pain-related TMDs, 36 subjects with myofascial pain (Ia), 14 with myofascial pain with
limited mouthopening (Ib), and 52 to the group of healthy controls (Figure 1). The sociode-
mographic characteristics of the total sample and the two groups of subjects are shown in
Table 1.
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Height (m) 1.62 0.09 1.65 0.10 1.60 0.08 0.005 
Body Mass Index 27.94 6.84 28.09 6.34 27.79 7.39 0.665 
Categorical F % F % F %  
Gender Male 25 24.5% 21 40.4% 4 8.0% <0.001 
Female 77 75.5% 31 59.6% 46 92.0%  
Academic 
level 
Primary 20 19.6% 13 25.0% 7 14.0% 0.036 
Secondary 51 50.0% 29 55.8% 22 44.0%  
University 31 30.4% 10 19.2% 21 42.0%  
Physical Ac-
tivity 
Yes 62 60.8% 34 65.4% 28 56.0% 0.438 
No 40 39.2% 18 34.6% 22 44.0%  
Smoking hab-
its 
No smoker 66 64.7% 31 59.6% 35 70.0% 0.731 
Smoker 14 13.7% 8 15.4% 6 12.0%  
Occasional smoker 9 8.8% 5 9.6% 4 8.0%  
Former smoker 13 12.7% 8 15.4% 5 10.0%  
Alcohol hab-
its 
No drinker 37 36.3% 19 36.5% 18 36.0% 0.937 
Habitual drinker 7 6.9% 4 7.7% 3 6.0%  
Occasional 58 56.9% 29 55.8% 29 58.0%  
Economic 
Level 
<20.000 € 63 61.8% 33 63.5% 30 60.0% 0.719 
>20.000 € 39 38.2% 19 36.5% 20 40.0%  
TMDs: Temporomandibular disorders; SD: Standard deviation; F: Frequency. 
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Variables All Participants No TMDs TMDs Differences
Continuous n = 102 n = 52 n = 50 p-Value
Mean SD Mean SD Mean SD
Age (Years) 47.07 13.79 48.85 14.67 45.18 12.67 0.184
Weight (Kg) 73.43 16.56 76.43 17.11 70.31 15.53 0.050
Height (m) 1.62 0.09 1.65 0.10 1.60 0.08 0.005
Body Mass Index 27.94 6.84 28.09 6.34 27.79 7.39 .665
Categorical F % F % F %
Gender
Male 25 24.5% 21 40.4% 4 8.0% <0.001
Female 77 75.5% 31 59.6% 46 92.0%
Academic
level
Primary 20 19.6% 13 25.0% 7 14.0% 0.036
Secondary 51 50.0% 29 55.8% 22 44.0%
University 31 30.4% 10 19.2% 21 42.0%
Physical
Activity
Yes 62 60.8% 34 65.4% 28 56.0% 0.438
No 40 39.2% 18 34.6% 22 44.0%
Smoking
habits
No smoker 66 64.7% 31 59.6% 35 70.0% 0.731
Smoker 14 13.7% 8 15.4% 6 12.0%
Occasional smoker 9 8.8% 5 9.6% 4 8.0%
Former smoker 13 12.7% 8 15.4% 5 10.0%
Alcohol
habits
No drinker 37 36.3% 19 36.5% 18 36.0% 0.937
Habitu l drinker 7 6.9% 4 7.7% 3 6.0%
Occa ional 58 56.9% 29 55.8% 29 58.0%
Economic
Level
<20.000 € 63 61.8% 33 63.5% 30 60.0% 0.719
>20.000 € 39 38.2% 19 36.5% 20 40.0%
TMDs: Temporomandibular disorders; SD: Standard deviation; F: Frequency.
The factor analysis showed a structure compatible with the existence of a single
factor (Figure 2) that explained 63% of the total variance (Table 2). The KMO of 0.835
(X2 = 225.516, p < 0.001) turned out to be satisfactory; therefore, the sample was suitable to
be analyzed by factor analysis.
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Item 1 9.74 6.137 0.681 0.549 0.816
Item 2 9.77 5.701 0.761 0.644 0.794
Item 3 9.97 5.415 0.707 0.556 0.804
Item 4 10.15 5.513 0.620 0.393 0.830
Item 5 10.06 5.739 0.568 0.345 0.844
a Cronbach’s alpha value if the item is deleted from the analysis. Items 1–5: Questions of the Short Form of the
Fonseca Anamnestic Index.
The reliability of the items measured with the Weighted Kappa showed values from
0.767 to 0.888 (Table 4). The test–retest reliability of the global score yielded an ICC value of
0.837, which can be considered as substantial reliability. The limits of agreement obtained
with the Bland and Altman analysis are shown in Figure 3. A SEM of 3.47 and a MDC of
6.79 were found.
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Table 4. Test–retest reliability of the items and the Short Form of the Fonseca Anamnestic Index
total score.
ITEM Weighted Kappa Lower Bound Upper Bound Reliability
Item 1 0.732 0.558 0.906 Substantial
Item 2 0.746 0.583 0.909 Substantial
Item 3 0.898 0.838 0.957 Almost perfect
Item 4 0.790 0.700 0.881 Substantial
Item 5 0.682 0.547 0.817 Substantial
Total score a 0.837 0.767 0.888 Substantial
a Intraclass correlation coefficient (ICC) value for the overall Short Form of the Fonseca Anamnestic Index score.
Items 1–5: Questions of the Short Form of the Fonseca Anamnestic Index.
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predictive value; −PV: negative predictive value.
he anish version of t e I s si ific t c rr l ti it t
ot er in ices of T assess e t an ith easures of orofacial pain, neck disability,
the eval ati of verti in the concurre t vali it a al sis. evertheless, t e correl ti
it c r i l i , - , I i t
of t e S statistical si ifi t
l . c ffici t t I t r ri l s.
Variable r Coefficient p-Value Correlation
FAI 0.876 <0.001 Strong
NRS orofacial pain 0.660 <0.001 Strong
NRS cervical p in 0.287 0.0 3 Po r
DHI functional 0.348 <0.001 Moderate
DHI emotional 0.404 <0.001 Moderate
DHI physical 0.409 <0.001 Moderate
SF-12 PCS 0.023 0.821 Poor
SF-12 MCS 0.353 <0. 01 Moderate
NDI 0.360 <0.001 Moderate
HIT-6 0.229 0.021 Poor
FAI: Fonseca Anamnestic Index; NRS: Numeric Pain Rating Scale; NDI: Neck Disability Index; SF-12 PCS: Short-
Form Health Survey Physical Component Summary; SF-12 MCS: Short-Form Health Survey Mental Component
Summary; DHI: Dizzi s Ha icap Inventory; HIT-6: The Headache Impact Test.
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4. Discussion
The present study assessed the characteristics of the SFAI, the short version of the FAI,
to evaluate TMDs in a Spanish-speaking population. The results report that this test is
valid and reliable, assesses severity, and shows the ability to differentiate between subjects
affected or not by TMDs. The mean time to complete the questionnaire was between one
and two minutes, making SFAI an ideal tool for use in primary care centers.
Our sample of subjects with TMDs had a higher proportion of women than men,
in line with evidence reported in the scientific literature. We believe that this sample is
representative of the TMD population, and although the control group differed in the
proportion of men and women with respect to the group of subjects, the analyses of ROC
curves by subgroups have provided similar information.
Fernandes Pires et al. developed and validated the SFAI for the first time in the
Brazilian population in 2017 [11] with a sample of 123 women, of which 57 suffered from
myogenic TMDs and 66 did not suffer from TMD symptoms. The patients were evaluated
using the Research Diagnostic Criteria for TMDs, and responded to the SFAI test twice
within a week. The results showed excellent reliability with an ICC of 0.95 in all items and
0.98 in the total score of the index. The sensitivity of the test was 0.97, with a cut-off point
of 17.5 points.
In general, the results of the previous study appear better than those obtained in
ours. This may be because Fernandes Pires’ sample set contained patients who were on
average 25 years younger than ours (47–48 years) and was composed only of women with
muscle disorders [11], while ours also included men. The original SFAI validation study
results can be extrapolated to other young populations with a greater capacity to respond
to simple instructions. In contrast, our study presents more modest but perhaps more
realistic results applicable to a broader population in terms of age and sex. Regarding the
test–retest reliability, the data from the original validation study are also exceptionally
high compared to ours. This may be because the authors used the ICC to measure the
reproducibility of the items, which is highly questionable as these items have an ordinal
response and the ICC should be applied to quantitative data. In our work, we used the
Weighted Kappa Index by quadratic weights, which is the appropriate measure for the
response scale of the items.
Sánchez-Torrelo et al. validated the Spanish version of the FAI in 2020 [14]. Compared
with the standard version of the FAI in Spanish, the short version is completed in half the
time. Nonetheless, the two scores are essentially equivalent and presenting a very high
correlation between the two (r = 0.88). The factorial validity of the standard version in
Spanish showed a structure with three factors, the first of which practically reproduces
the content of the SFAI, except for the inclusion of an additional item. We opted, however,
to keep the item structure of the original instrument in Portuguese. As in our study, the
test–retest reliability of the items ranged from substantial to almost perfect, although the
standard version of the FAI showed a reliability of the total score that could be considered
excellent, compared to a lower reliability obtained in our study for the short version
that could be considered substantial. The SEM was 6.28, and the MDC was 12.31 for
the standard version, which can be considered equivalent to the data obtained in our
study because the short scale has half as many items as the standard version. The internal
consistency showed a Cronbach’s α of 0.784, which is somewhat lower than the alpha
obtained in our study for the short version. Concurrent validity showed a low correlation
with the HIT-6 and PCS-SF12 tests, moderate correlation with the DHI, SF12, NDI, and
cervical pain NRS, and high correlation with the NRS for orofacial pain. The ROC curve
yielded an AUC of 0.865, a sensitivity of 82%, a specificity of 78%, and a cut-off point
>35 points. Regarding the ability to discriminate between subjects with and without TMDs,
the predictive values were very similar, with both sensitivity and specificity close to 80%.
In the case of the standard version, the cut-off point for the diagnosis of TMDs was more
than 35 points. In the short version in Spanish, this cut-off point was 10 points, which is
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equivalent to being able to screen any patient who answers positively to any of the items
as TMD and being able to rule out the disease only when the global score is zero.
Our study has several limitations. First, the sample size is tight, although it is similar
to the original valuation study. There were slight differences between the control and
comparison groups, justifiable by the higher prevalence of TMD among women. Moreover,
despite the wide age range used to increase generalizability, it could also be interpreted as a
limitation. However, few comparable studies exist, so we cannot reach further conclusions
in this regard. It should also be noted that the evaluators, although highly experienced
in the subject, were not calibrated. Furthermore, the sample set of subjects was obtained
in a very specific geographic area, so it would be desirable to analyze the results in
broader socio-cultural areas. Finally, and although our study analyzed the most common
psychometric properties, other properties of interest remain unknown such as whether
sensitivity to change or the ability to discriminate vary between different types of TMDs.
5. Conclusions
The Spanish version of the SFAI is a valid and reliable instrument for diagnosing
people with pain-related TMDs, with a test–retest reliability between “moderate” and
“substantial”, good internal consistency, and a good ability to differentiate between affected
and unaffected subjects. In addition, the correlation between SFAI and other specific
evaluation instruments for TMD is strong.
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